多元布局协同发力,蓄势高增驱动未来远大医药是一家科技驱动的国际化创新药企,近年来积极推进全球化布局与并购整合,旗下境内外附属公司超过30 家,构建了5 大技术平台和9 个研发中心,覆盖超200 个医保目录产品,过亿品种达16 个。公司核心业务涵盖核药抗肿瘤与心脑血管精准介入诊疗、制药科技、生物科技三大板块,已布局包括核药和脓毒症创新药在内的多条差异化管线。依托传统业务的扎实根基与创新管线的持续突破...
Source Link多元布局协同发力,蓄势高增驱动未来远大医药是一家科技驱动的国际化创新药企,近年来积极推进全球化布局与并购整合,旗下境内外附属公司超过30 家,构建了5 大技术平台和9 个研发中心,覆盖超200 个医保目录产品,过亿品种达16 个。公司核心业务涵盖核药抗肿瘤与心脑血管精准介入诊疗、制药科技、生物科技三大板块,已布局包括核药和脓毒症创新药在内的多条差异化管线。依托传统业务的扎实根基与创新管线的持续突破...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.